How these findings grew / Wound repair
GHK-Cu wound-healing research: closure, angiogenesis, and the matrix that rebuilds
The lineage that anchors the whole molecule — copper, collagen, and new blood vessels knitting a wound shut, read study by study.
Closure and angiogenesis in wound models
GHK-Cu wound-healing research is where the molecule's biology is most literal: a peptide that makes tissue grow, applied to tissue that needs to. A 2025 food-derived GHK-Cu self-healing hydrogel achieved over 95% infected-wound closure by day 12 in mice, versus about 65% in untreated controls, while showing antimicrobial activity against S. aureus and E. coli, reducing IL-6 and TNF-alpha, and stimulating collagen deposition and neovascularization [15]. The closure was driven by the same engine seen across the literature: angiogenesis.
Bioactive biomaterials make the mechanism visible. A photo-crosslinkable hyaluronic-acid hydrogel embedded with GHK peptide nanofibers accelerated healing with densely remodeled collagen and enhanced VEGF-driven angiogenesis, outperforming non-lipidated GHK and EGF for fibroblast proliferation and migration [7]. GHK-Cu-coated PCL/collagen/chitosan scaffolds (1 mM coating) improved human fibroblast viability after three days versus uncoated controls and showed antibacterial activity within one hour [10].
The remodeling profile behind the closure
Why GHK-Cu closes wounds is documented in the foundational tissue-remodeling review. It increases collagen, elastin, metalloproteinases and their anti-proteases, VEGF, FGF-2, NGF, and neurotrophins, while suppressing free radicals, thromboxane, TGF-beta-1, TNF-alpha, and protein glycation, and chemoattracting the macrophages, mast cells, and capillary cells that execute repair [6]. The angiogenic signal has an endogenous origin: proteolysis of SPARC releases GHK and KGHK peptides that stimulate angiogenesis, with KGHK most potent [9].
The trophic effect is dose-readable in cell systems. GHK-modified alginate hydrogels induced dose-dependent VEGF secretion from human mesenchymal stem cells via integrin alpha-6/beta-1 signaling, enhancing endothelial proliferation and tubule formation with no cytotoxicity at 1-500 ng/mL [8].